MacroGenics is pursuing alliances to participate in development of its proprietary product candidates and technology platforms.
Learn more
Enhancing the potency of therapeutic monoclonal antibodies via Fc optimization
Stavenhagen JB, Gorlatov S, Tuaillon N, Rankin CT, Li H, Burke S, Huang L, Johnson S, Koenig S, Bonvini E. Advances in Enzyme Regulation 2007 December 3. Link to full article
Go back